CN108434214A - 一种肠胃调理药物及其制备方法 - Google Patents
一种肠胃调理药物及其制备方法 Download PDFInfo
- Publication number
- CN108434214A CN108434214A CN201810459380.3A CN201810459380A CN108434214A CN 108434214 A CN108434214 A CN 108434214A CN 201810459380 A CN201810459380 A CN 201810459380A CN 108434214 A CN108434214 A CN 108434214A
- Authority
- CN
- China
- Prior art keywords
- temperature
- preparation
- hot
- stomach
- melt extruded
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 17
- 229940079593 drug Drugs 0.000 title claims abstract description 15
- 210000002784 stomach Anatomy 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 230000003750 conditioning effect Effects 0.000 title claims description 8
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims abstract description 32
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims abstract description 20
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims abstract description 17
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims abstract description 14
- 238000009835 boiling Methods 0.000 claims abstract description 11
- 229940109262 curcumin Drugs 0.000 claims abstract description 10
- 235000012754 curcumin Nutrition 0.000 claims abstract description 10
- 239000004148 curcumin Substances 0.000 claims abstract description 10
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 claims abstract description 10
- 238000001125 extrusion Methods 0.000 claims abstract description 8
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims abstract description 6
- 239000004359 castor oil Substances 0.000 claims abstract description 6
- 235000019438 castor oil Nutrition 0.000 claims abstract description 6
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims abstract description 6
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims abstract description 6
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims abstract description 6
- 238000002844 melting Methods 0.000 claims abstract description 6
- 230000008018 melting Effects 0.000 claims abstract description 6
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 6
- 239000001856 Ethyl cellulose Substances 0.000 claims abstract description 4
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229920001249 ethyl cellulose Polymers 0.000 claims abstract description 4
- 235000019325 ethyl cellulose Nutrition 0.000 claims abstract description 4
- 240000008866 Ziziphus nummularia Species 0.000 claims abstract 2
- 239000012943 hotmelt Substances 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 8
- 230000005540 biological transmission Effects 0.000 claims description 5
- 238000007872 degassing Methods 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 239000002893 slag Substances 0.000 claims description 4
- 230000005714 functional activity Effects 0.000 abstract description 4
- 210000000936 intestine Anatomy 0.000 abstract description 4
- 208000001848 dysentery Diseases 0.000 abstract description 3
- 241001247821 Ziziphus Species 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000002253 acid Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- XJLSEXAGTJCILF-RXMQYKEDSA-N (R)-nipecotic acid zwitterion Chemical compound OC(=O)[C@@H]1CCCNC1 XJLSEXAGTJCILF-RXMQYKEDSA-N 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001141 propulsive effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000007962 solid dispersion Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明公开了一种肠胃调理药物及其制备方法,将山樟子、红枣、太子参、红糖、蓖麻油与水煮沸制提取液,然后将提取液与γ‑氨基丁酸、姜黄素、黄原胶、乙基纤维素、羟丙基纤维素通过熔融、挤出、压片制得片剂。制得的药物能够调理肠胃,安全性高,同时对痢疾有显效,本发明将γ‑氨基丁酸与山樟子、姜黄素联合使用,能够有效增强其功能活性。
Description
技术领域
本发明涉及一种肠胃调理的药物及该药物的制备方法,属于生物技术领域。
背景技术
γ-氨基丁酸,英文名:γ-aminobutyric acid (GABA),化学名称:4-氨基丁酸,别名:γ-氨基丁酸,氨酪酸,哌啶酸。分子式:C4H9NO2。分子量:103.1。GABA是目前研究较为深入的一种重要的抑制性神经递质,它参与多种代谢活动,具有很高的生理活性。具有镇静、抗应激、促进食欲、调节内分泌等多种生物学功能。2009年9月27日,卫生部批准γ-氨基丁酸等六种物质为新资源食品,充分说明了γ-氨基丁酸极高的生物安全性。将γ-氨基丁酸应用于保健品、药品,用于改善肠胃功能是一个热门且意义重大的研究课题。本发明发现将γ-氨基丁酸与山樟子、姜黄素联合使用,能够有效增强其功能活性。
熔融挤压法创造性的将加工技术和药学结合起来,将高分子材料在玻璃化转变温度之上对其进行处理,促使热塑性粘合剂或聚合物、药物活性成分达到分子水平的有效混合。热熔挤出技术结合了固体分散体技术和机械制备的诸多优势,实现了无粉尘、连续化操作、良好的重现性、极高的生产效率和在线监测。不仅可以促进难溶性活性成分溶解从而提高其生物利用度,还可用于制备缓控释、肠溶制剂;此外,这一技术还能用于制备掩味微丸或者其它特殊形状的制剂,如膜剂、棒剂和空心圆柱剂型等。由于整个挤出过程持续时间很短且无须加入水或有机溶剂,不需加热干燥,因此不易发生水解问题。自从首次被应用于药物制剂领域开始,其完美解决传统制药工艺存在的诸多问题,已经成为国内外研究的热点技术。
发明内容
本发明的目的在于提供一种肠胃调理的药物及该药物的制备方法,制得的药物能够调理肠胃,安全性高,同时对痢疾有显效,本发明将γ-氨基丁酸与山樟子、姜黄素联合使用,能够有效增强其功能活性。
为实现上述目的,本发明采用如下技术方案:
取山樟子10g,红枣5g,太子参5g,红糖3g,蓖麻油2mL,加水200mL沸水蒸煮30min,过滤除渣,滤液加热浓缩至30mL,得到提取液。
在提取液中加入γ-氨基丁酸1-3g、姜黄素1-2g,溶解搅拌均匀,再与黄原胶5-10g、乙基纤维素5-25g、羟丙基纤维素 50-80g混合,混合后送入热熔挤出机,在热熔挤出机内进行加热熔融、挤出。热熔挤出机各区的温度设定为:喂料温度25-40℃,传输区温度35-60℃,混合区一段温度50-90℃,混合区二段温度80-140℃,混合区三段温度70-130℃,脱气区温度70-130℃,挤出区温度70-130℃。压片制成600mg片剂。
本发明的有益效果:调理肠胃,安全性高,同时对痢疾有显效。本发明将γ-氨基丁酸与山樟子、姜黄素联合使用,能够有效增强其功能活性。
具体实施方式
本发明用下列实施例来进一步说明本发明,但本发明的保护范围并不限于下列实施例。
实施例1
一种肠胃调理药物的制备方法,包括以下步骤:
(1)取山樟子10g,红枣5g,太子参5g,红糖3g,蓖麻油2mL,加水200mL沸水蒸煮30min,过滤除渣,滤液加热浓缩至30mL,得到提取液。
(2)在提取液中加入γ-氨基丁酸1g、姜黄素2g,溶解搅拌均匀,再与黄原胶7g、乙基纤维素15g、羟丙基纤维素 60g混合,混合后送入热熔挤出机,在热熔挤出机内进行加热熔融、挤出。热熔挤出机各区的温度设定为:喂料温度30℃,传输区温度50℃,混合区一段温度75℃,混合区二段温度115℃,混合区三段温度105℃,脱气区温度90℃,挤出区温度90℃。压片制成600mg片剂。
实施例2(最佳方案)
一种肠胃调理药物的制备方法,包括以下步骤:
(1)取山樟子10g,红枣5g,太子参5g,红糖3g,蓖麻油2mL,加水200mL沸水蒸煮30min,过滤除渣,滤液加热浓缩至30mL,得到提取液。
(2)在提取液中加入γ-氨基丁酸2g、姜黄素1.5g,溶解搅拌均匀,再与黄原胶8g、乙基纤维素25g、羟丙基纤维素 52.5g混合,混合后送入热熔挤出机,在热熔挤出机内进行加热熔融、挤出。热熔挤出机各区的温度设定为:喂料温度25℃,传输区温度45℃,混合区一段温度70℃,混合区二段温度115℃,混合区三段温度110℃,脱气区温度100℃,挤出区温度85℃。压片制成600mg片剂。
实施例3
一种肠胃调理药物的制备方法,包括以下步骤:
(1)取山樟子10g,红枣5g,太子参5g,红糖3g,蓖麻油2mL,加水200mL沸水蒸煮30min,过滤除渣,滤液加热浓缩至30mL,得到提取液。
(2)在提取液中加入γ-氨基丁酸3g、姜黄素1g,溶解搅拌均匀,再与黄原胶7g、乙基纤维素20g、羟丙基纤维素60g混合,混合后送入热熔挤出机,在热熔挤出机内进行加热熔融、挤出。热熔挤出机各区的温度设定为:喂料温度25℃,传输区温度45℃,混合区一段温度65℃,混合区二段温度125℃,混合区三段温度125℃,脱气区温度105℃,挤出区温度95℃。压片制成600mg片剂。
选择大约20g左右昆明种小鼠为实验对象,分两组,每组10只小鼠。试验组每天喂食实施例2所述片剂1次,每次喂食量为0.4mg/10g小鼠体重,连续喂食15天。对照组喂食等量饲料。然后给予营养性半固体黑色糊,观察小鼠胃排空,小肠推进运动的影响。与对照组相比,实验组小肠推进率提高了36.7%,胃内容物残留率显著降低。
以上所述仅为本发明的较佳实施案例,凡依本发明申请专利范围所做的均等变化与修饰,皆应属本发明的涵盖范围。
Claims (3)
1.一种肠胃调理药物的制备方法,其特征在于:包括以下步骤:
(1)取山樟子10g,红枣5g,太子参5g,红糖3g,蓖麻油2mL,加入200mL沸水蒸煮30min,过滤除渣,滤液浓缩至30mL,得到提取液;
(2)在提取液中加入γ-氨基丁酸1-3g、姜黄素1-2g,溶解搅拌均匀,再与黄原胶5-10g、乙基纤维素5-25g、羟丙基纤维素 50-80g混合,混合后送入热熔挤出机,在热熔挤出机内进行加热熔融、挤出,压片制成600mg片剂。
2.根据权利要求1所述的制备方法,其特征在于:热熔挤出机各区的温度设定为:喂料温度25-40℃,传输区温度35-60℃,混合区一段温度50-90℃,混合区二段温度80-140℃,混合区三段温度70-130℃,脱气区温度70-130℃,挤出区温度70-130℃。
3.如权利要求1或2所述的制备方法制得的肠胃调理药物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810459380.3A CN108434214A (zh) | 2018-05-15 | 2018-05-15 | 一种肠胃调理药物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810459380.3A CN108434214A (zh) | 2018-05-15 | 2018-05-15 | 一种肠胃调理药物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108434214A true CN108434214A (zh) | 2018-08-24 |
Family
ID=63203614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810459380.3A Pending CN108434214A (zh) | 2018-05-15 | 2018-05-15 | 一种肠胃调理药物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108434214A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104286999A (zh) * | 2013-07-15 | 2015-01-21 | 陈冠卿 | 健胃化食红枣浆 |
CN104430874A (zh) * | 2014-11-06 | 2015-03-25 | 蚌埠鲲鹏食品饮料有限公司 | 一种益气补血润肺加钙酸奶及其制作方法 |
CN105327285A (zh) * | 2015-12-01 | 2016-02-17 | 王平平 | 一种用于治疗胃窦炎的药物 |
-
2018
- 2018-05-15 CN CN201810459380.3A patent/CN108434214A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104286999A (zh) * | 2013-07-15 | 2015-01-21 | 陈冠卿 | 健胃化食红枣浆 |
CN104430874A (zh) * | 2014-11-06 | 2015-03-25 | 蚌埠鲲鹏食品饮料有限公司 | 一种益气补血润肺加钙酸奶及其制作方法 |
CN105327285A (zh) * | 2015-12-01 | 2016-02-17 | 王平平 | 一种用于治疗胃窦炎的药物 |
Non-Patent Citations (4)
Title |
---|
吴中朝: "《养好脾胃不生病》", 30 September 2016, 福建科学技术出版社 * |
唐祖宣: "《国医大师唐祖宣谈养生之道》", 31 July 2016, 中国医药科技出版社 * |
熊龙启 等: "熔融挤压法在工业药剂中的应用", 《中国医药工业杂志》 * |
褚洪彪 等: "《井冈山区域实用中草药图谱》", 31 July 2015, 第四军医大学出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104987422A (zh) | 用氨基酸修饰的玉米淀粉衍生物的制备方法 | |
CN103768112A (zh) | 一种芒果叶提取物及其应用 | |
CN106420629A (zh) | 支链氨基酸制剂及其制备方法和应用 | |
CN103920156B (zh) | 一种口服给药肠道定位释药薄膜包衣预混辅料及其制备方法 | |
CN108434214A (zh) | 一种肠胃调理药物及其制备方法 | |
CN105534945B (zh) | 一种植物型肠溶软胶囊 | |
CN108042503A (zh) | 一种高效的炎琥宁肠溶片及制备方法 | |
CN109170891A (zh) | 一种改善记忆力的组合物及其制备方法与应用 | |
CN105455131A (zh) | 一种大蒜沙棘油软胶囊的配方和制备工艺 | |
CN108379259A (zh) | 一种精神焦虑缓解药物及其制备方法 | |
CN108478627A (zh) | 一种解酒药物及其制备方法 | |
CN105434398B (zh) | 一种雷贝拉唑肠溶微丸及其制备方法 | |
CN108379351A (zh) | 一种降血压药物及其制备方法 | |
CN1857285A (zh) | 一种用于治疗心脑血管疾病的胶囊及其制备方法和应用 | |
CN105663025A (zh) | 一种含药微丝及其制备方法 | |
CN104857087A (zh) | 一种具有降血糖功效的药物制剂及其制备方法和应用 | |
CN101966225A (zh) | 一种益母草膏的制备方法 | |
CN104069242A (zh) | 一种复方阿胶浆的纳米组合物及其制备方法 | |
CN105250241A (zh) | 透皮贴剂的制备工艺 | |
CN108379457A (zh) | 一种安神助眠药物及其无水制备方法 | |
CN105061370B (zh) | 一种提高丹酚酸b稳定性的方法 | |
CN106074807A (zh) | 一种功劳去火片的制备方法 | |
CN103156106A (zh) | 一种由北五味子活性成分制备的降脂保肝药物或保健食品及制备方法 | |
CN103301074B (zh) | 一种甘草酸二铵肠溶微丸及其制备方法和制剂 | |
Benkimoun | Police find range of drugs after trawling bins used by Tour de France cyclists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180824 |